Cargando…

Clinical features and therapeutic responses to proton pump inhibitor in patients with severe reflux esophagitis: A multicenter prospective observational study

BACKGROUND AND AIM: In patients with severe erosive reflux disease (ERD; Los Angeles classification grade C/D) who do not undergo endoscopic examination, insufficient strength and duration of proton pump inhibitor (PPI) therapy may lead to complications such as esophageal bleeding and stenosis. Ther...

Descripción completa

Detalles Bibliográficos
Autores principales:	Isshi, Kimio, Matsuhashi, Nobuyuki, Joh, Takashi, Higuchi, Kazuhide, Iwakiri, Katsuhiko, Kamiya, Takeshi, Manabe, Noriaki, Nakada, Tatsuya, Ogawa, Maiko, Arihiro, Seiji, Haruma, Ken, Nakada, Koji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wiley Publishing Asia Pty Ltd 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812480/ https://www.ncbi.nlm.nih.gov/pubmed/33490619 http://dx.doi.org/10.1002/jgh3.12455

Ejemplares similares

Comparison of the effects of individual symptoms of gastroesophageal reflux disease co‐existing functional dyspepsia on patients' daily lives: A prospective, observational study
por: Nakada, Tatsuya, et al.
Publicado: (2022)

Clinical significance of gastroesophageal reflux disease with minimal change: a multicenter prospective observational study
por: Manabe, Noriaki, et al.
Publicado: (2022)

Development and validation of a simple and multifaceted instrument, GERD-TEST, for the clinical evaluation of gastroesophageal reflux and dyspeptic symptoms
por: Nakada, Koji, et al.
Publicado: (2017)

Recent effectiveness of proton pump inhibitors for severe reflux esophagitis: the first multicenter prospective study in Japan
por: Mizuno, Hideki, et al.
Publicado: (2015)

Sex differences in risk factors for future onset of reflux esophagitis
por: Osaga, Satoshi, et al.
Publicado: (2021)

Therapeutic strategy for the patients with coexisting gastroesophageal reflux disease and postprandial distress syndrome of functional dyspepsia
por: Isshi, Kimio, et al.
Publicado: (2020)

Predictive Factors for Future Onset of Reflux Esophagitis: A Longitudinal Case-control Study Using Health Checkup Records
por: Toki, Yuzuru, et al.
Publicado: (2022)

Factors associated with complicated erosive esophagitis: A Japanese multicenter, prospective, cross-sectional study
por: Sakaguchi, Masahiro, et al.
Publicado: (2017)

Efficacy and Safety Profile of Z-215 (Azeloprazole Sodium), a Proton Pump Inhibitor, Compared with Rabeprazole Sodium in Patients with Reflux Esophagitis: A Phase II, Multicenter, Randomized, Double-Blind, Comparative Study
por: Kinoshita, Yoshikazu, et al.
Publicado: (2018)

Clinical characteristics of elderly patients with proton pump inhibitor-refractory non-erosive reflux disease from the G-PRIDE study who responded to rikkunshito
por: Sakata, Yasuhisa, et al.
Publicado: (2014)

Proton Pump Inhibitor Induction of Gastric Cobblestone-like Lesions in the Stomach
por: Takahari, Kosuke, et al.
Publicado: (2017)

Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2021
por: Iwakiri, Katsuhiko, et al.
Publicado: (2022)

Effectiveness of screening endoscopy for esophageal squamous cell carcinoma in Japanese males
por: Nezu, Yasuko, et al.
Publicado: (2022)

Evaluation of the circumferential location of mild reflux esophagitis (Grade A and B) in the lower esophagus
por: Yamada, Akiyoshi, et al.
Publicado: (2022)

Black Spot, a Novel Gastric Finding Potentially Induced by Proton Pump Inhibitors
por: Hatano, Yu, et al.
Publicado: (2016)

Esophageal epiphrenic diverticulum associated with diffuse esophageal spasm
por: Matsumoto, Hideo, et al.
Publicado: (2015)

Contribution of Capsule Endoscopy Early in a Bleeding Episode to Treatment of Small Bowel Angioectasia: A Case Report
por: Arai, Yoshinori, et al.
Publicado: (2021)

Megaesophagus and Megaduodenum Found Incidentally on a Routine Chest Radiograph During a Health Examination
por: Arai, Yoshinori, et al.
Publicado: (2021)

Pathophysiology and treatment of patients with globus sensation ―from the viewpoint of esophageal motility dysfunction―
por: Manabe, Noriaki, et al.
Publicado: (2014)

Evaluation of symptomatic reflux esophagitis in proton pump inhibitor users
por: Asaoka, Daisuke, et al.
Publicado: (2019)

A Study on the Efficacy of Proton Pump Inhibitors in Helicobacter pylori-Negative Primary Care Patients with Dyspepsia in Japan
por: Kamada, Tomoari, et al.
Publicado: (2013)

The daily response for proton pump inhibitor treatment in Japanese reflux esophagitis and non-erosive reflux disease
por: Shida, Hiroshi, et al.
Publicado: (2013)

Outcomes of endoscopic submucosal dissection for gastroesophageal reflux disease (ESD-G) for medication-refractory gastroesophageal reflux disease: 35 cases underwent ESD-G including 15 cases followed more than 5 years
por: Ota, Kazuhiro, et al.
Publicado: (2021)

Foveolar gastric metaplasia presenting as a duodenal tumor with an atypical appearance: a case report
por: Abe, Takahiro, et al.
Publicado: (2016)

Efficacy of vonoprazan for initial and maintenance therapy in reflux esophagitis, nonerosive esophagitis, and proton pump inhibitor-resistant gastroesophageal reflux disease
por: Gotoh, Yasuhiko, et al.
Publicado: (2020)

Management of laryngopharyngeal reflux with proton pump inhibitors
por: Reimer, Christina, et al.
Publicado: (2008)

Liquid-containing Refluxes and Acid Refluxes May Be Less Frequent in the Japanese Population Than in Other Populations: Normal Values of 24-hour Esophageal Impedance and pH Monitoring
por: Kawamura, Osamu, et al.
Publicado: (2016)

Correlation between symptomatic improvement and quality of life in patients with reflux and dyspeptic symptoms
por: Arihiro, Seiji, et al.
Publicado: (2012)

Significantly Lower Saliva Secretion in Females With Gastroesophageal Reflux Disease and Healthy Subjects Than in Males
por: Momma, Eri, et al.
Publicado: (2023)

Daikenchuto significantly improves stool consistency and lower gastrointestinal symptoms in patients with chronic constipation
por: Manabe, Noriaki, et al.
Publicado: (2023)

Time esophageal pH < 4 overestimates the prevalence of pathologic esophageal reflux in subjects with gastroesophageal reflux disease treated with proton pump inhibitors
por: Gerson, Lauren B, et al.
Publicado: (2008)

The LHCb experiment
por: Nakada, Tatsuya, et al.
Publicado: (2000)

Risk Factors for Helicobacter pylori Infection and Endoscopic Reflux Esophagitis in Healthy Young Japanese Volunteers
por: Tanaka, Yuichiro, et al.
Publicado: (2017)

Relationship between time-varying status of reflux esophagitis and Helicobacter pylori and progression to long-segment Barrett’s esophagus: time-dependent Cox proportional-hazards analysis
por: Usui, Genki, et al.
Publicado: (2020)

Upper Esophageal Sphincter Compression Device as an Adjunct to Proton Pump Inhibition for Laryngopharyngeal Reflux
por: Yadlapati, Rena, et al.
Publicado: (2021)

Effects of rikkunshito on quality of life in patients with gastroesophageal reflux disease refractory to proton pump inhibitor therapy
por: Kawai, Takashi, et al.
Publicado: (2017)

Usefulness of 3-Dimensional Flexible Endoscopy in Esophageal Endoscopic Submucosal Dissection in an Ex Vivo Animal Model
por: Higuchi, Kazutoshi, et al.
Publicado: (2019)

Usefulness of ultrasonographic evaluation of stool and/or gas distribution for the treatment strategy of chronic constipation
por: Manabe, Noriaki, et al.
Publicado: (2019)

An Evaluation of Endoscopic Images from Over 15 Years Prior to the Diagnosis of Autoimmune Gastritis: A Report of Three Patients
por: Ayaki, Maki, et al.
Publicado: (2021)

Role of Acid and Weakly Acidic Reflux in Gastroesophageal Reflux Disease Off Proton Pump Inhibitor Therapy
por: Sung, Hea Jung, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_5op8dpgu131mctrgf9lsp3h9i8